Page last updated: 2024-10-27

fluoxetine and Craniofacial Microsomia

fluoxetine has been researched along with Craniofacial Microsomia in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research Excerpts

ExcerptRelevanceReference
" We present the occurrence of Goldenhar syndrome in an infant born to a woman with a history of prenatal Fluoxetine ingestion throughout her pregnancy."3.76Goldenhar syndrome associated with prenatal maternal Fluoxetine ingestion: Cause or coincidence? ( Awwad, J; Farra, C; Majdalani, M; Mikati, M; Yazbeck, N; Yunis, K, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farra, C1
Yunis, K1
Mikati, M1
Yazbeck, N1
Majdalani, M1
Awwad, J1

Other Studies

1 other study available for fluoxetine and Craniofacial Microsomia

ArticleYear
Goldenhar syndrome associated with prenatal maternal Fluoxetine ingestion: Cause or coincidence?
    Birth defects research. Part A, Clinical and molecular teratology, 2010, Volume: 88, Issue:7

    Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents, Second-Generation; Female; Fluoxetine; Go

2010